UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

AR‐V7 in circulating tumor cells cluster as a predictive biomarker of abiraterone acetate and enzalutamide treatment in castration‐resistant prostate cancer patients

The Prostate, 2018-06, Vol.78 (8), p.576-582

2018

Volltextzugriff (PDF)

Sexual activity and quality of life in Japanese pelvic organ prolapse patients after transvaginal mesh surgery

The journal of obstetrics and gynaecology research, 2018-07, Vol.44 (7), p.1302-1307

2018

Volltextzugriff (PDF)

Predictors of septic shock in obstructive acute pyelonephritis

World journal of urology, 2014-06, Vol.32 (3), p.803-811

2014

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated with Docetaxel Chemotherapy

International journal of molecular sciences, 2016-12, Vol.17 (12), p.2008-2008

2016

Volltextzugriff (PDF)

Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Three Years' Experience

Clinical journal of the American Society of Nephrology, 2011-10, Vol.6 (10), p.2499-2507

2011

Volltextzugriff (PDF)

Factors predicting decline in renal function and kidney volume growth in autosomal dominant polycystic kidney disease: a prospective cohort study (Japanese Polycystic Kidney Disease registry: J-PKD)

Clinical and experimental nephrology, 2021-09, Vol.25 (9), p.970-980

2021

Volltextzugriff (PDF)

Relationship between intracranial aneurysms and the severity of autosomal dominant polycystic kidney disease

Acta neurochirurgica, 2017-12, Vol.159 (12), p.2325-2330

2017

Volltextzugriff (PDF)

Evidence-based clinical practice guidelines for polycystic kidney disease 2014

Clinical and Experimental Nephrology, 2016-08, Vol.20 (4), p.493-509

2016

Volltextzugriff (PDF)

Supine versus prone position during percutaneous nephrolithotomy: a report from the clinical research office of the endourological society percutaneous nephrolithotomy global study

Journal of endourology, 2011-10, Vol.25 (10), p.1619-1625

2011

Volltextzugriff (PDF)

Japanese linguistic validation of the ureteral stent symptom questionnaire

International journal of urology, 2022-04, Vol.29 (4), p.332-336

2022

Volltextzugriff (PDF)

Age- and height-adjusted total kidney volume growth rate in autosomal dominant polycystic kidney diseases

Clinical and experimental nephrology, 2018-07, Vol.23 (1), p.100-111

2018

Volltextzugriff (PDF)

Optimal equation for estimation of glomerular filtration rate in autosomal dominant polycystic kidney disease: influence of tolvaptan

Clinical and experimental nephrology, 2018-10, Vol.22 (5), p.1213-1223

2018

Volltextzugriff (PDF)

PKD1-Associated Arachnoid Cysts in Autosomal Dominant Polycystic Kidney Disease

Journal of stroke and cerebrovascular diseases, 2021-09, Vol.30 (9), p.105943-105943, Article 105943

2021

Volltextzugriff (PDF)

Afatinib against Esophageal or Head-and-Neck Squamous Cell Carcinoma: Significance of Activating Oncogenic HER4 Mutations in HNSCC

Molecular cancer therapeutics, 2016-08, Vol.15 (8), p.1988-1997

2016

Volltextzugriff (PDF)

Intratumor Heterogeneity in Primary Kidney Cancer Revealed by Metabolic Profiling of Multiple Spatially Separated Samples within Tumors

EBioMedicine, 2017-05, Vol.19 (C), p.31-38

2017

Volltextzugriff (PDF)

Renal disease progression in autosomal dominant polycystic kidney disease

Clinical and experimental nephrology, 2012-08, Vol.16 (4), p.622-628

2012

Volltextzugriff (PDF)

Alternative antiandrogen therapy in patients with castration-resistant prostate cancer: A single-center experience

International journal of urology, 2010-11, Vol.17 (11), p.950-955

2010

Volltextzugriff (PDF)

Association of circulating tumor cells with tumor-related methylated DNA in patients with hormone-refractory prostate cancer

International journal of urology, 2010-05, Vol.17 (5), p.466-475

2010

Volltextzugriff (PDF)

Kidney volume and function in autosomal dominant polycystic kidney disease

Clinical and experimental nephrology, 2014-02, Vol.18 (1), p.157-165

2014

Volltextzugriff (PDF)

A potentially crucial role of the PKD1 C-terminal tail in renal prognosis

Clinical and experimental nephrology, 2018-04, Vol.22 (2), p.395-404

2018

Volltextzugriff (PDF)

Long-Term Outcomes of Longitudinal Efficacy Study With Tolvaptan in ADPKD

Kidney international reports, 2022-02, Vol.7 (2), p.270-281

2022

Volltextzugriff (PDF)

Development and Validation of a Novel Recurrence Risk Stratification for Initial Non-muscle Invasive Bladder Cancer in Asia

EBioMedicine, 2016-10, Vol.12 (C), p.98-104

2016

Volltextzugriff (PDF)

Estimation of Changes in Kidney Volume Growth Rate in ADPKD

Kidney international reports, 2020-09, Vol.5 (9), p.1459-1471

2020

Volltextzugriff (PDF)

Immunomagnetic quantification of circulating tumor cells in patients with urothelial cancer

International journal of urology, 2010-03, Vol.17 (3), p.254-258

2010

Volltextzugriff (PDF)

1 – 25 von 132

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(96)

Publikationsform

Artikel
(130)
Berichte
(2)

Sprache

Englisch
(108)
Japanisch
(27)

Erscheinungsjahr

n.n

Thema

Humans
(83)
Science & Technology
(71)
Life Sciences & Biomedicine
(70)
Male
(65)
Urology & Nephrology
(56)
Middle Aged
(52)
Aged
(45)
Female
(44)
Adult
(28)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Urology
(22)
Aged, 80 And Over
(20)
Nephrology. Urinary Tract Diseases
(18)
Prognosis
(17)
Autosomal Dominant Polycystic Kidney Disease
(15)
Prostatic Neoplasms - Pathology
(15)
Medicine
(13)
Prostate-Specific Antigen - Blood
(13)
Treatment Outcome
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

AR‐V7 in circulating tumor cells cluster as a predictive biomarker of abiraterone acetate and enzalutamide treatment in castration‐resistant prostate cancer patients

Sexual activity and quality of life in Japanese pelvic organ prolapse patients after transvaginal mesh surgery

Predictors of septic shock in obstructive acute pyelonephritis

Epidermal Growth Factor Receptor Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated with Docetaxel Chemotherapy

Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Three Years' Experience

Technical Evaluation: Identification of Pathogenic Mutations in PKD1 and PKD2 in Patients with Autosomal Dominant Polycystic Kidney Disease by Next-Generation Sequencing and Use of a Comprehensive New Classification System

Factors predicting decline in renal function and kidney volume growth in autosomal dominant polycystic kidney disease: a prospective cohort study (Japanese Polycystic Kidney Disease registry: J-PKD)

Relationship between intracranial aneurysms and the severity of autosomal dominant polycystic kidney disease

Evidence-based clinical practice guidelines for polycystic kidney disease 2014

Supine versus prone position during percutaneous nephrolithotomy: a report from the clinical research office of the endourological society percutaneous nephrolithotomy global study

Japanese linguistic validation of the ureteral stent symptom questionnaire

Age- and height-adjusted total kidney volume growth rate in autosomal dominant polycystic kidney diseases

Optimal equation for estimation of glomerular filtration rate in autosomal dominant polycystic kidney disease: influence of tolvaptan

PKD1-Associated Arachnoid Cysts in Autosomal Dominant Polycystic Kidney Disease

Afatinib against Esophageal or Head-and-Neck Squamous Cell Carcinoma: Significance of Activating Oncogenic HER4 Mutations in HNSCC

Intratumor Heterogeneity in Primary Kidney Cancer Revealed by Metabolic Profiling of Multiple Spatially Separated Samples within Tumors

Renal disease progression in autosomal dominant polycystic kidney disease

Alternative antiandrogen therapy in patients with castration-resistant prostate cancer: A single-center experience

Association of circulating tumor cells with tumor-related methylated DNA in patients with hormone-refractory prostate cancer

Kidney volume and function in autosomal dominant polycystic kidney disease

A potentially crucial role of the PKD1 C-terminal tail in renal prognosis

Long-Term Outcomes of Longitudinal Efficacy Study With Tolvaptan in ADPKD

Development and Validation of a Novel Recurrence Risk Stratification for Initial Non-muscle Invasive Bladder Cancer in Asia

Estimation of Changes in Kidney Volume Growth Rate in ADPKD

Immunomagnetic quantification of circulating tumor cells in patients with urothelial cancer

Suchergebnisse filtern